PMV PHARMACEUTICALS INC (PMVP) Stock Price, Quote, News and Overview
NASDAQ:PMVP - Nasdaq - US69353Y1038 - Common Stock - Currency: USD
PMVP Quote, Performance and Key Statistics
1.07
-0.02 (-1.83%)
The current stock price of PMVP is 1.07 USD. In the past month the price increased by 18.89%. In the past year, price decreased by -33.95%.
PMVP Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 17.89 | 324.59B | ||
| AMGN | AMGEN INC | 13.12 | 146.49B | ||
| GILD | GILEAD SCIENCES INC | 13.72 | 132.09B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | N/A | 113.90B | ||
| REGN | REGENERON PHARMACEUTICALS | 11.55 | 55.27B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 40.83B | ||
| ARGX | ARGENX SE - ADR | 94.05 | 33.02B | ||
| ONC | BEONE MEDICINES LTD-ADR | 6.58 | 27.86B | ||
| BNTX | BIONTECH SE-ADR | N/A | 24.76B | ||
| NTRA | NATERA INC | N/A | 23.26B | ||
| INSM | INSMED INC | N/A | 19.20B | ||
| BIIB | BIOGEN INC | 7.89 | 18.28B |
Related stock screener links
About PMVP
Company Profile
PMV Pharmaceuticals, Inc. is a precision oncology company, which engages in the discovery and development of small molecule, tumor-agnostic therapies targeting p53. The company is headquartered in Princeton, New Jersey and currently employs 63 full-time employees. The company went IPO on 2020-09-25. The firm is engaged in the discovery and development of small molecule, tumor-agnostic therapies targeting p53. p53 is a well-defined tumor suppressor protein known as the guardian of the genome, and normal, or wild type, p53 has the ability to eliminate cancer cells. The company is deploying its precision oncology platform to target p53 mutations and other p53-related cancers. Its lead product candidate, rezatapopt, is designed to be an orally available small molecule that structurally corrects the mutant p53 protein with the Y220C mutation. In addition to its rezatapopt program, it is focused on developing a pipeline of product candidates targeting other p53 mutations or p53-related targets. These programs have been developed using its precision oncology platform.
Company Info
PMV PHARMACEUTICALS INC
400 Alexander Park Drive, Suite 301
Princeton NEW JERSEY 08512 US
CEO: David H. Mack
Employees: 47
Phone: 16096426670
PMV PHARMACEUTICALS INC / PMVP FAQ
What is the stock price of PMV PHARMACEUTICALS INC today?
The current stock price of PMVP is 1.07 USD. The price decreased by -1.83% in the last trading session.
What is the ticker symbol for PMV PHARMACEUTICALS INC stock?
The exchange symbol of PMV PHARMACEUTICALS INC is PMVP and it is listed on the Nasdaq exchange.
On which exchange is PMVP stock listed?
PMVP stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for PMV PHARMACEUTICALS INC stock?
11 analysts have analysed PMVP and the average price target is 5.61 USD. This implies a price increase of 424.3% is expected in the next year compared to the current price of 1.07. Check the PMV PHARMACEUTICALS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is PMV PHARMACEUTICALS INC worth?
PMV PHARMACEUTICALS INC (PMVP) has a market capitalization of 55.59M USD. This makes PMVP a Micro Cap stock.
How many employees does PMV PHARMACEUTICALS INC have?
PMV PHARMACEUTICALS INC (PMVP) currently has 47 employees.
What are the support and resistance levels for PMV PHARMACEUTICALS INC (PMVP) stock?
PMV PHARMACEUTICALS INC (PMVP) has a support level at 1.06 and a resistance level at 1.1. Check the full technical report for a detailed analysis of PMVP support and resistance levels.
Should I buy PMV PHARMACEUTICALS INC (PMVP) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of PMVP, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of PMVP, evaluating the profitability, health, valuation and growth aspects
- PMV PHARMACEUTICALS INC (PMVP) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- PMV PHARMACEUTICALS INC (PMVP) Sales and EPS estimates to see what analysts future expectations are.
- PMV PHARMACEUTICALS INC (PMVP) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- PMV PHARMACEUTICALS INC (PMVP) Insider and Institutional Ownership to learn about the owners and their transactions.
- PMV PHARMACEUTICALS INC (PMVP) Stock Chart to make your own analysis
- PMV PHARMACEUTICALS INC (PMVP) Latest news and press-releases to stay up to date.
Does PMV PHARMACEUTICALS INC (PMVP) stock pay dividends?
PMVP does not pay a dividend.
When does PMV PHARMACEUTICALS INC (PMVP) report earnings?
PMV PHARMACEUTICALS INC (PMVP) will report earnings on 2025-08-06, before the market open.
What is the Price/Earnings (PE) ratio of PMV PHARMACEUTICALS INC (PMVP)?
PMV PHARMACEUTICALS INC (PMVP) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.18).
What is the Short Interest ratio of PMV PHARMACEUTICALS INC (PMVP) stock?
The outstanding short interest for PMV PHARMACEUTICALS INC (PMVP) is 1.95% of its float. Check the ownership tab for more information on the PMVP short interest.
PMVP Technical Analysis
ChartMill assigns a technical rating of 4 / 10 to PMVP. When comparing the yearly performance of all stocks, PMVP is a bad performer in the overall market: 85.5% of all stocks are doing better.
PMVP Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to PMVP. While PMVP has a great health rating, there are worries on its profitability.
PMVP Financial Highlights
Over the last trailing twelve months PMVP reported a non-GAAP Earnings per Share(EPS) of -1.18. The EPS increased by 11.28% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -35.68% | ||
| ROE | -38.02% | ||
| Debt/Equity | 0 |
PMVP Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 85% to PMVP. The Buy consensus is the average rating of analysts ratings from 11 analysts.